Korean Circ J.  2019 Jul;49(7):600-601. 10.4070/kcj.2019.0179.

Will Ticagrelor Help Post-Myocardial Infarction ‘Healing’?

• Park KW

• KMID: 2450390
• DOI: http://doi.org/10.4070/kcj.2019.0179

Abstract

No abstract available.

MeSH Terms

Infarction*

Reference

1. Burchfield JS, Xie M, Hill JA. Pathological ventricular remodeling: mechanisms: part 1 of 2. Circulation. 2013; 128:388–400.

2. Liehn EA, Postea O, Curaj A, Marx N. Repair after myocardial infarction, between fantasy and reality: the role of chemokines. J Am Coll Cardiol. 2011; 58:2357–2362.

3. Tapp LD, Shantsila E, Wrigley BJ, Pamukcu B, Lip GY. The CD14⁺⁺CD16⁺ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction. J Thromb Haemost. 2012; 10:1231–1241.

4. Storey RF, Angiolillo DJ, Patil SB, et al. Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy. J Am Coll Cardiol. 2010; 56:1456–1462.

5. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009; 361:1045–1057.

6. Du XJ, Shan L, Gao XM, et al. Role of intramural platelet thrombus in the pathogenesis of wall rupture and intra-ventricular thrombosis following acute myocardial infarction. Thromb Haemost. 2011; 105:356–364.

7. Ye Y, Birnbaum GD, Perez-Polo JR, Nanhwan MK, Nylander S, Birnbaum Y. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction. Arterioscler Thromb Vasc Biol. 2015; 35:1805–1814.

8. Kim EK, Park TK, Yang JH, et al. Ticagrelor versus clopidogrel on myocardial infarct size in patients undergoing primary percutaneous coronary intervention. J Am Coll Cardiol. 2017; 69:2098–2099.

9. Yun KH, Rhee SJ, Ko JS. Comparison of the infarct size between the loading of ticagrelor and clopidogrel in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Korean Circ J. 2017; 47:705–713.

10. Park Y, Choi SW, Oh JH, et al. Rationale and design of the high platelet inhibition with ticagrelor to improve left ventricular remodeling in patients with ST-segment elevation myocardial infarction (HEALING-AMI) trial. Korean Circ J. 2019; 49:586–599.